ForumIAS LATEST
- 04 June | MGP Strategy Series | GS Paper 4 (Ethics) with AIR 7 A.R. Rajah Mohaideen Click Here to register for the session →
- 04 June | GS Advance Program begins from 4th June 2026 | First 2 classes open to all Click Here to register for the event →
- 05 June | MGP Strategy Series | GS Paper 3 Strategy Session with AIR 406 Mannat Luthra Click Here to register for the session
- 06 June | Open Orientation on Essay Guidance Program (EGP 2026) Click Here to register →
- 07 June | Open Orientation for Current Affairs for Mains 2026 Click Here to register →
- 07 June | Sociology Optional Strategy Session with AIR 10 Ujjwal Priyank Click Here to register →
- According to World Health Organisation (WHO),around 40% of the essential medicines in India are priced significantly higher than estimated production costs.This shows the amount of profiteering done by pharmaceutical companies and the scope for lowering the prices of drugs.
- The drugs used for cancer,hepatitis C and off patent drugs which are in the market for long and commonly used for diseases like HIV,tuberculosis and malaria are priced very high with huge margins over their cost of production.
- This results in high expenditure which pushes people into poverty.In India over 75% of health expenditure is out-of-pocket,of which the major chunk is spent on medicines.This is despite India being a manufacturing hub and the biggest supplier of low cost generic medicines to the world.
- Further,most of the high-priced medicines in India were found only in the private market which suggests a lack of availability in public facilities.
